Poultry Vaccines Market Size To Reach $3.66 Billion By 2030

Poultry Vaccines Market Growth & Trends

The global poultry vaccines market size is expected to reach USD 3.66 billion in 2030 and is projected to grow at a CAGR of 7.60% from 2025 to 2030. The key factors driving the market include the rising consumption of poultry meat and eggs, the prevalence of avian diseases, and the increasing poultry population in key markets. According to OECD-FAO Agricultural Outlook, poultry meat consumption in the U.S. was pegged at 19,169 thousand tons in 2020. This consumption is projected to increase over the next few years.

The COVID-19 pandemic resulted in several challenges for the poultry industry including a fall in consumption, increased concerns over zoonoses, and low sales. For example, as per the Economic Times, in March 2020, the price of chicken plunged by as much as 70% due to the reduced consumption of meat, fish, eggs, and chicken. However, the pandemic also led to the rising awareness regarding diseases in animals and increasing demand for safe and healthy poultry products. This is anticipated to create opportunities for poultry vaccines manufacturers as poultry farms must ensure healthy layer, broiler, and breeder stock. In fact, in April 2021, the CEO & MD of Hester Biosciences Ltd. stated that the market for poultry vaccines is set to grow significantly post COVID.

In addition, the advent of new vaccines, such as Salmonella-vectored vaccines, which protect domesticated birds against necrotic enteritis is anticipated to provide a growth platform to this market. In addition, the rising usage of poultry vaccines by research institutes and colleges, along with vaccination awareness programs, is fueling the growth of the market. For instance, in July 2019, the Veterinary College and Research Institute based in Madurai, India started vaccinating domesticated birds, predominantly chickens, to save farmers from suffering significant losses.

Technological advancements in poultry vaccines, rising demand for animal protein, concerns over food safety, animal welfare, and microbial resistance, increased focus on avian healthcare, and shift from treatment to the prevention of diseases are some of the other factors anticipated to create growth opportunities in the market. For instance, the TAbic Vaccines Line by Phibro Animal Health Corporation comprises 25+ vaccines for poultry for protection against Newcastle disease, infectious bronchitis, and other poultry diseases.

 Request a free sample copy or view report summary: Poultry Vaccines Market Report

Poultry Vaccines Market Report Highlights

• The increasing prevalence of infectious diseases in poultry and product developments in the field are anticipated to create growth opportunities in the market

• By product, attenuated live vaccines held the largest revenue share in 2024 owing to their relatively low production cost and long duration of protection

• The Egg Drop Syndrome (EDS) disease type segment is expected to register a lucrative growth rate over the forecast period due to the growing use of inactivated vaccines to prevent viral disease

• As per the MSD Vet Manual, EDS vaccines can also be given in combination with other vaccines, such as those for Newcastle disease, thus increasing their adoption rate

• The breeder application segment dominated the market in 2024 due to the increasing use of vaccines at breeder farms to secure the health of the poultry and increase farm’s productivity

• The North America poultry vaccines market dominated the global market and accounted for 37.7% of the total revenue share in 2024. This is due to a number of factors including the existence of major market participants, rising animal protein consumption, and advancements in technology.

Poultry Vaccines Market Segmentation

Grand View Research has segmented the global poultry vaccines market based on application, vaccine type, disease type, route of administration, distribution channel, and region:

Poultry Vaccines Application Outlook (Revenue, USD Million, 2018 - 2030)

• Brolier

• Layer

• Breeder

Poultry Vaccines Vaccine Type Outlook (Revenue, USD Million, 2018 - 2030)

• Modified/ Attenuated Live

• Inactivated (Killed)

• Other Vaccines

Poultry Vaccines Disease type Outlook (Revenue, USD Million, 2018 - 2030)

• Infectious Bronchitis

• Infectious Bursal Diseases

• Infectious Laryngotracheitis

• Egg Drop Syndrome

• Adenovirus

• Duck Viral Enteritis

• Inclusion Body Hepatitis

• Coccidiosis

• Avian Influenza

• Marek's Disease

• Newcastle Disease

• Salmonella

• Avian Encephalomyelitis

• Fowl Cholera

Poultry Vaccines Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)

• Injectable

• Intranasal

Poultry Vaccines Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Retail

• E-Commerce

• Hospital/Clinic Pharmacies

Poultry Vaccines Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Sweden

  • Denmark

  • Norway

  • Rest of Europe

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

  • Rest of Asia-Pacific 

• Latin America

  • Brazil

  • Argentina

  • Rest of LA

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

  • Rest of MEA

List of Key Players in the Poultry Vaccines Market

• Boehringer Ingelheim International GmbH

• Zoetis Services LLC

• Vaxxinova International BV

• Merck & Co., Inc.

• Calier

• KM Biologics (Meiji Animal Health)

• Elanco

• Hester Biosciences Limited

• Ceva Santé Animale

• Phibro Animal Health Corporation